News Focus
News Focus
Followers 118
Posts 5004
Boards Moderated 4
Alias Born 07/31/2020

Re: Techroemancer post# 45375

Thursday, 11/13/2025 3:10:06 PM

Thursday, November 13, 2025 3:10:06 PM

Post# of 45732
Correct, given CellHelmet growth over the last two years vs. a company with no revenue does get the wheels turning.

So, I'm wondering if CellHelmet loved BKTH's product enough to say "hey, let's do this.". I'm wondering if CellHelmet wanted to be a publicly traded company, but due to the fees, it'd be easier to be absorbed into a pre-existing company that aligns with their vision as well as having the capability to scale their product and their market with a unique glass coating technology.


It does beg the question; why would they give up control of their company to jump into a company with little to no revenue history?

On the flip side, we all know there are a ton of shells in OTC land that can be obtained for less than a million dollars. Only one problem, the majority have skeletons in the closet (associated legal risk) have billions in AS (vs. RS completed) and have little to no documented (audited) financial records. To say nothing as it relates to have a product that they are likely under a 5-year contract to perform that will only benefits their business model.

When CellHelmet weighs all the Pros and Cons as laid out above, one can begin to understand why I believe this deal will be completed, unless they find something in the closet that raises more questions than it answers. However, having the audited financials here is going to greatly improve the odds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y